Buprenorphine transdermal skin patch and Pentamycetin Ophthalmic Solution 0.25%
Determining the interaction of Buprenorphine transdermal skin patch and Pentamycetin Ophthalmic Solution 0.25% and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: chloramphenicol ophthalmic
Brand name:
Synonyms: Chloramphenicol (Ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Pentamycetin Ophthalmic Solution 0.5%
- Buprenorphine transdermal skin patch-Pentasa
- Buprenorphine transdermal skin patch-Pentasa Rectal
- Buprenorphine transdermal skin patch-Pentazocine
- Buprenorphine transdermal skin patch-Pentazocine Acetaminophen
- Buprenorphine transdermal skin patch-Pentazocine and Naloxone
- Pentamycetin Ophthalmic Solution 0.25%-Buprenorphine, Buprenorphine Hydrochloride
- Pentamycetin Ophthalmic Solution 0.25%-Buprenorphine/naloxone Oromucosal, Sublingual
- Pentamycetin Ophthalmic Solution 0.25%-Buproban
- Pentamycetin Ophthalmic Solution 0.25%-Bupropion
- Pentamycetin Ophthalmic Solution 0.25%-Bupropion and naltrexone
- Pentamycetin Ophthalmic Solution 0.25%-Bupropion Extended-Release Tablets